Skip to main content


Sana Symposium 2022
Official Meeting of the Psychedelic Medicine Association
Psychedelics Education for Mental Health & Addiction Professionals

Sa · na
(v) to heal.

The field of psychedelics is evolving quickly. Sana Symposium is your number one resource to stay up to date on the latest clinical advances, research breakthroughs, and expert-guided strategies. In 2021, more than 1,000 motivated clinicians participated in this one-of-a-kind educational experience, uniting globally renowned experts across psychiatry, psychotherapy, and addiction treatment to provide diverse perspectives on the successful practice of psychedelic therapies.

Join the movement. Uncover promising results in utilizing this new treatment option to treat mental health disorders including major depression, anxiety, and PTSD. Now is the time to prepare yourself and your practice for this next wave of revolutionary treatment.

Registration launching soon! Join our mailing list for the latest updates.

Rick Doblin, PHD

In 3 days, gain the confidence and know-how to effectively guide patients interested in psychedelic therapies, and set the stage for a smooth transition of this new treatment option into your practice.

Empowered Clinicians
Innovative Sessions
Practice-Changing Days
Who Should Attend?

Sana Symposium is designed and accredited for all members of mental health and addiction treatment teams. This is the place to broaden your perspective, embrace innovation, and partake in an inclusive conference program where efficiency and effectiveness are paramount.

Nurse Practitioners
Physician Assistants
Primary Care Physicians
Social Workers
Students, Residents, and Fellows
Other Mental Health & Addiction Professionals
Meet the Steering Committee

Sana Symposium is partnering with nine world-renowned educators, practitioners, and research trailblazers in the field of psychedelics to make this inaugural 2021 conference an insightful, practical, and impactful educational experience.

Kwasi Adusei, DNP, PMHNP
Co-founder, Psychedelic Society of Western New York
Robin Carhart-Harris, PhD
Director, Centre for Psychedelic Research, Imperial College London
Rick Doblin, PhD
Founder and Executive Director, Multidisciplinary Association for Psychedelic Studies (MAPS)
Rakesh Jain, MD, MPH
Clinical Professor, Department of Psychiatry, Texas Tech Health Sciences Center School of Medicine, Midland, Texas
Saundra Jain, MA, PsyD, LPC
Adjunct Clinical Affiliate, University of Texas at Austin School of Nursing; Private Practice, Austin, Texas
Lynn Marie Morski, MD, ESQ
President, Psychedelic Medicine Association
Andrew Penn, RN, MS, NP, CNS, APRN-BC
Associate Clinical Professor, University of California, San Francisco, California
Charles Raison, MD
Director of Clinical and Translational Research, Usona Institute
Rosalind Watts, PhD
Clinical Director, The Synthesis Institute
Psychedelics, when used wisely, have the potential to heal us, help inspire us, and perhaps even save us."

Rick Doblin, PhD
Founder & Executive Director, Multidisciplinary Association for Psychedelic Studies

Psychedelic agents have a long history of human use, almost always reserved for sacred rituals. The reason for that is because they induced very profound changes in perception, thought, and feeling."

Charles Raison, MD
Chair, Clinical Advisory Board, Usona

In Partnership with